Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Fu Hung

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Gynecologic Oncology|December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and TherapeuticsDeyin Xing, Gang Zheng, Aparna Pallavajjala, et al.
Journal of Gastroenterology and Hepatology|April 14, 2024
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registryRheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, et al.
Plos One|September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitorsRavi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
Mbio|October 4, 2023
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojectorShiwen Peng, Hsin-Fang Tu, Michelle Cheng, et al.
Human Pathology|August 23, 2019
Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulvaDeyin Xing, Yuehua Liu, Hyeon Jin Park, et al.
Cell Reports|October 14, 2021
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potentialBrandon Lam, Yu Jui Kung, John Lin, et al.
NAR Cancer|June 25, 2024
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancersSelina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, et al.
Advanced Healthcare Materials|December 17, 2013
Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growthMing Yang, Tao Yu, Ying-Ying Wang, et al.
The Journal of Clinical Investigation|May 15, 2026
Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancerSelina Shiqing K Teh, Akhil Kotwal, Alexis Bennett, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Gynecologic Oncology|December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and TherapeuticsDeyin Xing, Gang Zheng, Aparna Pallavajjala, et al.
Journal of Gastroenterology and Hepatology|April 14, 2024
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registryRheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang, et al.
Plos One|September 10, 2021
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitorsRavi K Anchoori, Logan George, Ssu-Hsueh Tseng, et al.
Mbio|October 4, 2023
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojectorShiwen Peng, Hsin-Fang Tu, Michelle Cheng, et al.
Human Pathology|August 23, 2019
Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulvaDeyin Xing, Yuehua Liu, Hyeon Jin Park, et al.
Cell Reports|October 14, 2021
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potentialBrandon Lam, Yu Jui Kung, John Lin, et al.
NAR Cancer|June 25, 2024
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancersSelina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, et al.
Advanced Healthcare Materials|December 17, 2013
Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growthMing Yang, Tao Yu, Ying-Ying Wang, et al.
The Journal of Clinical Investigation|May 15, 2026
Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancerSelina Shiqing K Teh, Akhil Kotwal, Alexis Bennett, et al.
Pageof 27